Gabriel Melo de Oliveira

Author

Also Known As

G.M. Oliveira, GABRIEL M. OLIVEIRA, Gabriel Berbert de Oliveira, Gabriel Lédo Pereira de Oliveira, Gabriel M Oliveira, Gabriel M. Oliveira, Gabriel M. de Oliveira, Gabriel Melo De Oliveira, Gabriel Melo Oliveira, Gabriel Melo de Oliveira

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Georgia State University Universidade Federal do Rio de Janeiro Universidade Federal Fluminense Universidade Federal de São Paulo

About

Gabriel Melo de Oliveira is an author at Fundação Oswaldo Cruz specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	516
2	Natural Sciences	4	4	148
3	Health Sciences	2	2	26
4	Social Sciences	2	2	46
5	Allergy	1	1	34

Gabriel Melo de Oliveira

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man Francisco Lopera, Claudia Mariño, Anita Chandrahas, Nature Medicine	2023	179
Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira, Antimicrobial Agents and Chemotherapy	2010	79
Pharmacological Inhibition of Transforming Growth Factor β Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease Mariana Caldas Waghabi, Elen Mello de Souza, Gabriel Melo de Oliveira, Antimicrobial Agents and Chemotherapy	2009	68
Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease Fabiane Loiola de Oliveira, Tânia Cremonini de Araújo-Jorge, Elen Mello de Souza, PLoS neglected tropical diseases	2012	66
In Vitro and In Vivo Studies of the Trypanocidal Activity of a Diarylthiophene Diamidine against <i>Trypanosoma cruzi</i> Cristiane França da Silva, Marcos Meuser Batista, Denise da Gama Jaén Batista, Antimicrobial Agents and Chemotherapy Antiparasitic AgentAromatic DiamidinesImmunologyDiarylthiophene DiamidinePathology	2008	63
Fas Ligand-Dependent Inflammatory Regulation in Acute Myocarditis Induced by Trypanosoma cruzi Infection Gabriel Melo de Oliveira, Rafaela Lopes Diniz, Wanderson Silva Batista, American Journal Of Pathology InflammationAcute Myocarditis InducedAutoimmune DiseaseAfrican TrypanosomiasisTrypanosoma Cruzi Infection	2007	45
Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies Maria de Nazaré Correia Soeiro, A.P. Dantas, Anissa Daliry, Memórias do Instituto Oswaldo Cruz Bioorganic ChemistryAntiparasitic AgentImmunologyGastroenterologyPathology	2009	39
Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection Andréa Pereira de Souza, Gabriel Melo de Oliveira, Jean Vanderpas, Parasitology Research Selenium DeficiencyAfrican TrypanosomiasisPathologySelenium SupplementationToxicology	2003	38
In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection Cristiane França da Silva, Denise da Gama Jaén Batista, Gabriel Melo de Oliveira, PLoS ONE Antiparasitic AgentTrypanosoma Cruzi InfectionMalariaImmunologyPathology	2012	37
The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice Andréa Pereira de Souza, Linda A. Jelicks, Herbert B. Tanowitz, Memórias do Instituto Oswaldo Cruz	2010	36

Page 1